Kenji Yoshida

MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study

Richard Pötter, Kari Tanderup, Maximilian Schmid et al. · The Lancet Oncology · 2021 · 583 citations

Adaptive Radiotherapy, Advanced Cervical Cancer, Cervical Cancer +11

Isothiazolone Derivatives Selectively Inhibit Telomerase from Human and Rat Cancer Cells <i>in Vitro</i>

Nobuki Hayakawa, Katsura Nozawa, Akio Ogawa et al. · Biochemistry · 1999 · 88 citations

Tmpi Inhibition, Medicinal Chemistry, Oncogenic Agent +10

Down-regulation of Telomerase Activity Is an Early Event in the Differentiation of HL60 Cells

Ericka Savoysky, Kenji Yoshida, Toshihiko Ohtomo et al. · Biochemical and Biophysical Research Communications · 1996 · 82 citations

Chromatin, Cell Regulation, Cell Division +12

Efficacy of stereotactic body radiotherapy for hepatocellular carcinoma with portal vein tumor thrombosis/inferior vena cava tumor thrombosis: evaluation by comparison with conventional three-dimensional conformal radiotherapy

Yoshiro Matsuo, Kenji Yoshida, Hideki Nishimura et al. · Journal of Radiation Research · 2016 · 73 citations · Full text

Clinical results of combined treatment conformal high-dose-rate iridium-192 brachytherapy and external beam radiotherapy using staging lymphadenectomy for localized prostate cancer

Junichi Hiratsuka, Yoshimasa Jo, Kenji Yoshida et al. · International Journal of Radiation Oncology*Biology*Physics · 2004 · 69 citations

Clinical Results, Surgical Oncology, Radiation Therapy +9